Third Dissemination Event of the ProCAncer-I Project in Athens

Published on: May 30, 2024
Categories: Events | News

ProCAncer-I organised the 3rd Dissemination Event of the project at the 21st IEEE International Symposium on Biomedical Imaging, held in Athens, Greece, May 27-30, 2024. During the symposium, ProCAncer-I organised the WorkshopIntegrating imaging Data and AI models for supporting precision care through prostate cancer’s continuum”, on the 27th of May. Prof. Kostas Marias, Prof. Haridimos Kondylakis, Prof. Daniele Regge, Dr. Sara Colantonio and Dr. Manuel Marfil Trujillo discussed and presented various issues on imaging data and AI modeling in the health sector.

The ISBI conference series is jointly organized by the IEEE Signal Processing Society and the IEEE Engineering in Medicine and Biology Society, and its top priority is to strengthen the synergy between researchers and experts from academia, healthcare organizations, research institutions, and industry towards advancing research and innovation in the field of biomedical imaging. This year and while ISBI will cover all areas related to medical image computing, it will extend its focus to emerging AI frontiers in biomedical imaging, including interpretability, domain shifts and adaptation, trustworthiness, as well as on issues related to in-silico modelling, virtual twins, precision medicine, and clinical applications.

Ana Castro Verde from Champalimaud Foundation also presented a poster on the accepted 4-page paper also at the same symposium.

 

Highlights

ProCAncer-I at the EMUC24 in Lisbon

ProCAncer-I at the EMUC24 in Lisbon

The progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices will comprise the scientific programme of the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24), which will take place from 7 to 10...

AI in PCa imaging : The current status and future perspectives

AI in PCa imaging : The current status and future perspectives

Ιn recent years, magnetic resonance imaging (MRI) has transformed the prostate cancer (PCa) diagnostic pathway, based on the evidence of multiple high-level evidence studies (refs 4M, MRI first, and PROMIS). Taken together, the evidence indicates that prostate MRI...

Open Call To Include New Beneficiaries Into The EUCAIM Consortium

Open Call To Include New Beneficiaries Into The EUCAIM Consortium

The EUCAIM project is launching an open call for new beneficiaries to join the consortium. The objective of the EUCAIM open call is to: i) onboard new cancer image data holders, increasing the geographic dimensions, data modalities or cancer targets, and  ii) include...

Stay in touch!